These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 30745146)

  • 41. A cohort study of the effectiveness of influenza vaccine in older people, performed using the United Kingdom general practice research database.
    Mangtani P; Cumberland P; Hodgson CR; Roberts JA; Cutts FT; Hall AJ
    J Infect Dis; 2004 Jul; 190(1):1-10. PubMed ID: 15195237
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effectiveness of trivalent inactivated influenza vaccine among community-dwelling older adults in Thailand: A two-year prospective cohort study.
    Prasert K; Patumanond J; Praphasiri P; Siriluk S; Ditsungnoen D; Chittaganpich M; Dawood FS; Mott JA; Lindblade KA
    Vaccine; 2019 Feb; 37(6):783-791. PubMed ID: 30616956
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparative Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccines Among US Medicare Beneficiaries in Preventing Postinfluenza Deaths During 2012-2013 and 2013-2014.
    Shay DK; Chillarige Y; Kelman J; Forshee RA; Foppa IM; Wernecke M; Lu Y; Ferdinands JM; Iyengar A; Fry AM; Worrall C; Izurieta HS
    J Infect Dis; 2017 Feb; 215(4):510-517. PubMed ID: 28329311
    [TBL] [Abstract][Full Text] [Related]  

  • 44. 2015/16 seasonal vaccine effectiveness against hospitalisation with influenza A(H1N1)pdm09 and B among elderly people in Europe: results from the I-MOVE+ project.
    Rondy M; Larrauri A; Casado I; Alfonsi V; Pitigoi D; Launay O; Syrjänen RK; Gefenaite G; Machado A; Vučina VV; Horváth JK; Paradowska-Stankiewicz I; Marbus SD; Gherasim A; Díaz-González JA; Rizzo C; Ivanciuc AE; Galtier F; Ikonen N; Mickiene A; Gomez V; Kurečić Filipović S; Ferenczi A; Korcinska MR; van Gageldonk-Lafeber R; ; Valenciano M
    Euro Surveill; 2017 Jul; 22(30):. PubMed ID: 28797322
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Influenza vaccine effectiveness in older adults compared with younger adults over five seasons.
    Russell K; Chung JR; Monto AS; Martin ET; Belongia EA; McLean HQ; Gaglani M; Murthy K; Zimmerman RK; Nowalk MP; Jackson ML; Jackson LA; Flannery B
    Vaccine; 2018 Feb; 36(10):1272-1278. PubMed ID: 29402578
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effectiveness of influenza vaccination in preventing hospitalisations of elderly individuals in two influenza seasons: a multicentre case-control study, Spain, 2013/14 and 2014/15.
    Domínguez A; Soldevila N; Toledo D; Godoy P; Espejo E; Fernandez MA; Mayoral JM; Castilla J; Egurrola M; Tamames S; Astray J; Morales-Suárez-Varela M;
    Euro Surveill; 2017 Aug; 22(34):. PubMed ID: 28857047
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Can routinely collected laboratory and health administrative data be used to assess influenza vaccine effectiveness? Assessing the validity of the Flu and Other Respiratory Viruses Research (FOREVER) Cohort.
    Kwong JC; Buchan SA; Chung H; Campitelli MA; Schwartz KL; Crowcroft NS; Jackson ML; Karnauchow T; Katz K; McGeer AJ; McNally JD; Richardson DC; Richardson SE; Rosella LC; Simor A; Smieja M; Zahariadis G; Campigotto A; Gubbay JB
    Vaccine; 2019 Jul; 37(31):4392-4400. PubMed ID: 31221563
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Statin Use and Risks of Influenza-Related Outcomes Among Older Adults Receiving Standard-Dose or High-Dose Influenza Vaccines Through Medicare During 2010-2015.
    Izurieta HS; Chillarige Y; Kelman JA; Forshee R; Qiang Y; Wernecke M; Ferdinands JM; Lu Y; Wei Y; Xu W; Lu M; Fry A; Pratt D; Shay DK
    Clin Infect Dis; 2018 Jul; 67(3):378-387. PubMed ID: 29438483
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Assessing Residual Bias in Estimating Influenza Vaccine Effectiveness: Comparison of High-dose Versus Standard-dose Vaccines.
    Butler AM; Layton JB; Krueger WS; Kshirsagar AV; McGrath LJ
    Med Care; 2019 Jan; 57(1):73-78. PubMed ID: 30422840
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effectiveness of the influenza vaccine in preventing admission to hospital and death in people with type 2 diabetes.
    Vamos EP; Pape UJ; Curcin V; Harris MJ; Valabhji J; Majeed A; Millett C
    CMAJ; 2016 Oct; 188(14):E342-E351. PubMed ID: 27455981
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Influenza vaccine effectiveness in the elderly based on administrative databases: change in immunization habit as a marker for bias.
    Hottes TS; Skowronski DM; Hiebert B; Janjua NZ; Roos LL; Van Caeseele P; Law BJ; De Serres G
    PLoS One; 2011; 6(7):e22618. PubMed ID: 21818350
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effectiveness of Influenza Vaccination Among Older Adults Across Kidney Function: Pooled Analysis of 2005-2006 Through 2014-2015 Influenza Seasons.
    Ishigami J; Sang Y; Grams ME; Coresh J; Chang A; Matsushita K
    Am J Kidney Dis; 2020 Jun; 75(6):887-896. PubMed ID: 31813664
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effectiveness of adjuvanted seasonal influenza vaccines (Inflexal V ® and Fluad ® ) in preventing hospitalization for influenza and pneumonia in the elderly: a matched case-control study.
    Gasparini R; Amicizia D; Lai PL; Rossi S; Panatto D
    Hum Vaccin Immunother; 2013 Jan; 9(1):144-52. PubMed ID: 23143775
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Low influenza vaccine effectiveness and the effect of previous vaccination in preventing admission with A(H1N1)pdm09 or B/Victoria-Lineage in patients 60 years old or older during the 2015/2016 influenza season.
    Puig-Barberà J; Guglieri-López B; Tortajada-Girbés M; López-Labrador FX; Carballido-Fernández M; Mollar-Maseres J; Schwarz-Chavarri G; Baselga-Moreno V; Mira-Iglesias A; Díez-Domingo J;
    Vaccine; 2017 Dec; 35(52):7331-7338. PubMed ID: 29128380
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cost Benefit of High-Dose vs Standard-Dose Influenza Vaccine in a Long-Term Care Population During an A/H1N1-Predominant Influenza Season.
    Shireman TI; Ogarek J; Gozalo P; Zhang T; Mor V; Davidson HE; Han L; Taljaard M; Gravenstein S
    J Am Med Dir Assoc; 2019 Jul; 20(7):874-878. PubMed ID: 30777631
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High-dose inactivated influenza vaccine is associated with cost savings and better outcomes compared to standard-dose inactivated influenza vaccine in Canadian seniors.
    Becker DL; Chit A; DiazGranados CA; Maschio M; Yau E; Drummond M
    Hum Vaccin Immunother; 2016 Dec; 12(12):3036-3042. PubMed ID: 27669017
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cost-effectiveness of high-dose versus standard-dose inactivated influenza vaccine in adults aged 65 years and older: an economic evaluation of data from a randomised controlled trial.
    Chit A; Becker DL; DiazGranados CA; Maschio M; Yau E; Drummond M
    Lancet Infect Dis; 2015 Dec; 15(12):1459-66. PubMed ID: 26362172
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of Previous-Year Vaccination on the Efficacy, Immunogenicity, and Safety of High-Dose Inactivated Influenza Vaccine in Older Adults.
    DiazGranados CA; Dunning AJ; Robertson CA; Talbot HK; Landolfi V; Greenberg DP
    Clin Infect Dis; 2016 May; 62(9):1092-1099. PubMed ID: 26908801
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effectiveness of influenza vaccine in the elderly.
    Nichol KL; Margolis KL; Wouremna J; von Sternberg T
    Gerontology; 1996; 42(5):274-9. PubMed ID: 8940650
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Live attenuated or inactivated influenza vaccines and medical encounters for respiratory illnesses among US military personnel.
    Wang Z; Tobler S; Roayaei J; Eick A
    JAMA; 2009 Mar; 301(9):945-53. PubMed ID: 19255113
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.